OPC-6535

( DrugBank: - / KEGG DRUG: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	2

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	8

96. クローン病

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00989573 (ClinicalTrials.gov)	October 2009	2/10/2009	A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease	A Multinational, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-finding and Confirm ...	Crohn's Disease	Drug: Placebo;Drug: OPC-6535	Otsuka Pharmaceutical Co., Ltd.	NULL	Completed	18 Years	64 Years	Both	191	Phase 2/Phase 3	Japan;Korea, Republic of
2	NCT00317369 (ClinicalTrials.gov)	May 2006	21/4/2006	A Dose-Finding Study of OPC-6535 in Patients With Active Crohn's Disease	A Dose-Finding Study of OPC-6535 in Patients With Active Crohn's Disease	Crohn Disease	Drug: OPC-6535(Tetomilast)	Otsuka Pharmaceutical Co., Ltd.	NULL	Terminated	16 Years	65 Years	Both	60	Phase 2	Japan

First Previous1Next Last

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

trials per page:

Showing 1 to 8 of 8 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00317356 (ClinicalTrials.gov)	May 2006	21/4/2006	A Dose-Finding Study of OPC-6535 in Patients With Active Ulcerative Colitis	A Dose-Finding Study of OPC-6535 in Patients With Active Ulcerative Colitis	Colitis, Ulcerative	Drug: OPC-6535(Tetomilast)	Otsuka Pharmaceutical Co., Ltd.	NULL	Terminated	18 Years	65 Years	Both	160	Phase 2	Japan
2	EUCTR2005-003724-19-CZ (EUCTR)	21/11/2005	05/10/2005	A Phase 3, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-arm Study of the Eff ...	A Phase 3, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-arm Study of the Eff ...	Active Ulcerative Colitis MedDRA version: 8.0;Level: LLT;Classification code 10058816	Product Name: OPC-6535 Product Code: OPC-6535 INN or Proposed INN: Not applicable Other descriptive nam ...	Otsuka Maryland Research Institute, Inc.	NULL	Not Recruiting			Female: yes Male: yes	375	Phase 3	Hungary;Czech Republic
3	EUCTR2005-003724-19-HU (EUCTR)	24/10/2005	07/09/2005	A Phase 3, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-arm Study of the Eff ...	A Phase 3, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-arm Study of the Eff ...	Active Ulcerative Colitis MedDRA version: 8.0;Level: LLT;Classification code 10058816	Product Name: OPC-6535 Product Code: OPC-6535 INN or Proposed INN: Not applicable Other descriptive nam ...	Otsuka Maryland Research Institute, Inc.	NULL	Not Recruiting			Female: yes Male: yes	375	Phase 3	Czech Republic;Hungary
4	EUCTR2004-000611-25-IE (EUCTR)	19/10/2004	16/08/2004	A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, 52-Week Dose Comparison Study of the ...	A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, 52-Week Dose Comparison Study of the ...	Maintenance of remission of ulcerative colitis	Product Name: OPC-6535 Product Code: OPC-6535 Other descriptive name: 6-[2-(3,4-diethoxyphenyl)thiazol ...	Otsuka Maryland Research Institute, Inc.	NULL	Not Recruiting			Female: yes Male: yes	1725	Phase 3	Hungary;Ireland
5	EUCTR2004-000611-25-HU (EUCTR)	15/10/2004	21/07/2004	A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, 52-Week Dose Comparison Study of the ...	A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, 52-Week Dose Comparison Study of the ...	Maintenance of remission of ulcerative colitis	Product Name: OPC-6535 Product Code: OPC-6535 Other descriptive name: 6-[2-(3,4-diethoxyphenyl)thiazol ...	Otsuka Maryland Research Institute, Inc.	NULL	Not Recruiting			Female: yes Male: yes	1725	Phase 3	Hungary;Ireland
6	NCT00092508 (ClinicalTrials.gov)	May 2004	22/9/2004	CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission	Phase 3, Multi-Center, Randomized, Double-Blind, Parallel-Arm, 52-Week Dose Comparison Study of the ...	Ulcerative Colitis	Drug: OPC-6535;Drug: Asacol®	Otsuka Pharmaceutical Development & Commercialization, Inc.	NULL	Completed	18 Years	80 Years	Both	1725	Phase 3	United States
7	NCT00064441 (ClinicalTrials.gov)	May 2003	8/7/2003	FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active ...	FACTS I: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm Study of ...	Ulcerative Colitis	Drug: OPC-6535 Tablets (drug)	Otsuka Pharmaceutical Development & Commercialization, Inc.	NULL	Completed	18 Years	80 Years	Both	375	Phase 3	United States
8	NCT00064454 (ClinicalTrials.gov)	May 2003	8/7/2003	FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Activ ...	FACTS II: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm Study o ...	Ulcerative Colitis	Drug: OPC-6535 Tablets (drug)	Otsuka Pharmaceutical Development & Commercialization, Inc.	NULL	Completed	18 Years	80 Years	Both	375	Phase 3	United States

First Previous1Next Last